Literature DB >> 22514367

Seroprevalence of antibodies against human herpesvirus 6 in the Quebec City area.

L Deschênes1, J R Joly, M Couillard, G Richer.   

Abstract

Seroprevalence of antibodies against human herpesvirus 6 was determined in a sample of 303 randomly selected individuals from the Quebec City area. The influence of different variables on antibody litres was also evaluated. Human herpesvirus 6 was grown in the HSB-2 cell line, and antibody litres were measured by indirect immunofluorescence. Serum samples were collected from 177 females and 126 males ranging in age from two months to 88 years. Ninety-nine per cent (300 of 303) of this population had an antibody titre of at least 1:10, whereas 75% had a titre of at least 1:80. Women had a higher geometric mean litre than men (P=0.06). This difference between sexes varied according to age and became statistically significant in subjects older than 20 years of age (P=0.04). It was found that this difference was attributable to higher antibody litres in women in the 15 to 40 year age group who had previously had children.

Entities:  

Keywords:  Exanthem subitum; Human herpesvirus 6 (HHV6); Indirect immunofluorescence; Roseola; Seroprevalence

Year:  1992        PMID: 22514367      PMCID: PMC3328037          DOI: 10.1155/1992/837029

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  35 in total

1.  Genomic analysis of the human B-lymphotropic virus (HBLV).

Authors:  S F Josephs; S Z Salahuddin; D V Ablashi; F Schachter; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

2.  HBLV (or HHV-6) in human cell lines.

Authors:  D V Ablashi; S Z Salahuddin; S F Josephs; F Imam; P Lusso; R C Gallo; C Hung; J Lemp; P D Markham
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

3.  Random digit dialing.

Authors:  A T Wielgosz; E Nicholls; E Biro; L MacWilliam; Y Mao
Journal:  Can J Public Health       Date:  1987 May-Jun

4.  Antibody to both human herpesvirus 6 and cytomegalovirus.

Authors:  W L Irving; A L Cunningham; A Keogh; J R Chapman
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

5.  Age prevalence of antibody to human herpesvirus 6.

Authors:  M Briggs; J Fox; R S Tedder
Journal:  Lancet       Date:  1988-05-07       Impact factor: 79.321

6.  Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers.

Authors:  A Linde; E Fridell; H Dahl; J Andersson; P Biberfeld; B Wahren
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Occupational risk for primary cytomegalovirus infection among pediatric health-care workers.

Authors:  M E Dworsky; K Welch; G Cassady; S Stagno
Journal:  N Engl J Med       Date:  1983-10-20       Impact factor: 91.245

8.  Identification of human herpesvirus-6 as a causal agent for exanthem subitum.

Authors:  K Yamanishi; T Okuno; K Shiraki; M Takahashi; T Kondo; Y Asano; T Kurata
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

9.  Evaluation of variables in immunofluorescence procedures for the detection of antibodies against human herpesvirus 6 (HHV-6).

Authors:  M Couillard; J R Joly; L Deschênes; G Richer
Journal:  Diagn Microbiol Infect Dis       Date:  1992 May-Jun       Impact factor: 2.803

10.  Frequent isolation of HHV-6 from saliva and high seroprevalence of the virus in the population.

Authors:  J A Levy; F Ferro; D Greenspan; E T Lennette
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

View more
  1 in total

1.  Human herpesvirus 6 and chronic fatigue syndrome.

Authors:  D Eymard; F Lebel; M Miller; F Turgeon
Journal:  Can J Infect Dis       Date:  1993-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.